Medical Clinic · Pratumnak Hill, Pattaya
★★★★★ 5.0 · 47 Google reviews · Walk-in clinic · Pratumnak Hill
Educational information. MOTS-C is not offered as a product for healthy adults or normal aging. Any therapy is individualized, physician-supervised and reserved for appropriate medical indications. Always consult a doctor.
MOTS-C is a 16-amino-acid mitochondrial-derived peptide — encoded within the mitochondrial 12S rRNA — that acts as a metabolic regulator, activating the AMPK pathway and influencing insulin sensitivity in research models. We’ll be honest: the strong evidence is preclinical, human data are limited, and it is not an approved medicine. At our Peptide Department walk-in clinic on Pratumnak Hill, Pattaya, we run it only as a physician-supervised, prescription-only research-peptide: physician-supervised and evidence-based. Ask our medical team via WhatsApp in around two minutes.
Dedicated Department
Peptide Department with its own protocols and follow-up structure.
Pharmacy-Verified
Compounded under licensed Bangkok pharmacy, COA-certified.
Evidence-Based
Every claim on this page links to its primary research source.
Lab-Verified
Every batch prepared by a licensed Thai compounding pharmacy with documentation.
Walk-in clinic · Pattaya
In person or online
Real doctor time, your way
Visit our Pattaya clinic in person, or book an online consultation from anywhere in Thailand — the same physician-led care either way.
Serving all Pattaya
Central Pattaya to Jomtien & Chonburi
In-person patients come to us from Central Pattaya, Jomtien, Naklua, Pratumnak and across greater Chonburi — and we consult online nationwide.
For travellers
Travel certificate available
Travelling with a prescribed therapy? We can provide a medical certificate to support your journey.
No referral needed. Visit our Pattaya clinic for a consultation and an honest, physician-led assessment. MOTS-C at TRT Bangkok is provided through a dedicated Peptide Department with its own protocols, communication system and follow-up structure.
Outside Pattaya?
Not in Pattaya? Book an online consultation with our medical team — same honest, physician-led guidance, just remote.
Book an online consultation →The Science
MOTS-C is a 16-amino-acid mitochondrial-derived peptide — encoded within the mitochondrial 12S rRNA. In research it acts as a metabolic regulator, activating the AMPK pathway and influencing insulin sensitivity. Importantly, the strongest data are preclinical, and we frame it that way.
Mechanism 1
Mitochondrial-derived peptide
MOTS-C is encoded within mitochondrial DNA (12S rRNA) — a signalling peptide the cell makes itself, described in the founding paper (Lee et al., Cell Metab, 2015 · PMID 25738959).
Mechanism 2
AMPK & insulin sensitivity
In mice, MOTS-C regulated metabolic homeostasis via AMPK and prevented age- and high-fat-diet-induced insulin resistance and diet-induced obesity — a preclinical metabolic signal (Lee et al., 2015 · PMID 25738959).
Mechanism 3
Muscle & fat metabolism
Reviews describe MOTS-C as a novel mitochondrial-derived peptide regulating muscle and fat metabolism — sometimes called an “exercise mimetic” in preclinical work (Merry et al. review, Free Radic Biol Med, 2016 · PMID 27216708).
The MOTS-C evidence is largely preclinical; robust human clinical-outcome trials are lacking, and it is not an approved medicine. We provide it only as an eligibility-reviewed, physician-supervised research-peptide — and say so plainly.
Every mechanism above is backed by peer-reviewed research — and every claim on this page links to its primary source.
What the research shows
MOTS-C is studied as a metabolic-signalling peptide — interesting biology in models, but early human evidence. We keep expectations honest.
Pathway
AMPK metabolic signalling
Activates AMPK in preclinical models — the master metabolic sensor linked to insulin sensitivity and energy balance.
Evidence
Mostly preclinical
The metabolic effects are documented in mice and cells; human clinical-outcome data are limited.
Access
Physician-supervised, on prescription
Eligibility review first; no self-administration and no published fixed dose — and honest about its research status.
If your goal is metabolic weight management with strong human evidence, our GLP-1 programs are the better-supported route — we’ll point you there.
Regulatory status & safety
Approval status
Is MOTS-C an approved medicine?
MOTS-c is a naturally occurring mitochondrial-derived peptide studied for metabolism. It is at an early research stage and is not an approved medicine; any use is experimental and off-label.
A key caution
Who should be careful
Human evidence is early. It is best understood as a research-stage compound, not a proven therapy — which is why we frame it as information, not a product.
Generally not appropriate in: pregnancy, active cancer, expectation of guaranteed results.
What a clinician monitors
Sensible checks before & during use
Honest about side effects
Possible side effects
This is why MOTS-C belongs in a physician-led conversation, not an off-the-shelf purchase — honest risk disclosure and the right monitoring are part of using it responsibly.
Medically reviewed by the TRT Bangkok Peptide Department · a licensed medical clinic in Pattaya, Thailand. Last reviewed August 2026. Every clinical claim on this page links to its primary research source.
Compare the options
How MOTS-C compares with the other cellular/longevity peptides people ask about — including how early or established the evidence really is.
| Peptide | Class | Pattern / half-life | Studied for | Approval |
|---|---|---|---|---|
| SS-31 (elamipretide) | Mitochondria-targeted peptide | Protects mitochondrial membranes | Mitochondrial function (trials) | Investigational |
| MOTS-c | Mitochondrial-derived peptide | Metabolic signalling | Metabolism (early research) | Not approved |
| Epithalon (epitalon) | Synthetic tetrapeptide | Pineal / telomere research | Cellular aging (older research) | Not approved |
| GHK-Cu | Copper tripeptide | Topical vs systemic differ | Skin, collagen, repair | Cosmetic ingredient (topical) |
Which (if any) is appropriate depends on your goal, your history and your labs — that’s the conversation to have with a doctor, not a decision to make from a table.
Quality & sourcing
This is one of the most overlooked parts of peptide safety. Much of what is sold online as “research” peptide is unregulated, and quality varies enormously. When something is going into a body, the source is not a detail — it is the whole point.
Identity & purity
Is it actually the peptide claimed, at the stated concentration — or under-dosed, mislabeled, or something else entirely?
Sterility
Was it produced and handled under conditions that are actually safe for injection?
Endotoxin contamination
Bacterial byproducts that can trigger fever and inflammatory reactions.
Heavy metals & impurities
Contaminants that have no place in anything you put into your body.
Storage & handling
Many peptides are fragile and temperature-sensitive; poor storage or shipping can degrade a product long before it is used.
Our position
If anything is ever appropriate for you, it is handled to medical standards from a quality-controlled source — and that decision is made with a doctor, not a checkout.
The safest way to answer “where should this come from?” is to bring the question to a clinician. We’re happy to talk it through — honestly, with no pressure.
How it works at our clinic
This is an educational page, not a checkout. We don’t sell MOTS-C off the shelf. If it is clinically appropriate for you, any use is individualized and physician-supervised — here’s the path.
1
Understand the science
We explain what MOTS-C does — and what the human evidence does and does not support — in plain language, with every claim linked to its source.
2
Consultation & assessment
A medical review of your goals and history — and, where relevant, testing. A doctor decides suitability, and will say so honestly if a better-evidenced option fits.
3
Supervised, if appropriate
Only if suitable: a protocol set individually and monitored. Prescription-only, no published one-size dosing, first administration guided at our Pattaya clinic.
There is no public price and no “order” button, by design: MOTS-C is a medical matter, handled through consultation at a real, licensed Pattaya clinic.
Patient Reviews
from 48 verified Google reviews
Patients who choose our Peptide Department for MOTS-C want a physician-supervised, honestly-framed program — not preclinical hype sold as fact. Every vial is physician-supervised and grounded in the evidence; these ratings come live from our Google Business Profile and are refreshed regularly.
Verified patients
Real Google reviews
Updated regularly
Straight from our profile
Walk-in clinic
Pratumnak Hill, Pattaya
The research behind MOTS-C
MOTS-C has a compelling molecular story from mitochondrial biology and metabolism — predominantly in preclinical models. We link the primary sources and keep the human-evidence caveat front and centre.
Founding paper
Lee C, et al. Cell Metab, 2015 · PMID 25738959
Identified MOTS-C as a mitochondrial-derived peptide that promotes metabolic homeostasis via AMPK and reduces obesity and insulin resistance in mice. PubMed
Review · muscle & fat
Merry TL, et al. Free Radic Biol Med, 2016 · PMID 27216708
Reviews MOTS-C as a novel mitochondrial-derived peptide regulating muscle and fat metabolism — the “exercise-mimetic” framing seen in preclinical work. PubMed
Evidence status · honest
Preclinical, not an approved medicine
MOTS-C is not FDA-approved and robust human outcome trials are lacking. We provide it as an eligibility-reviewed, physician-supervised research-peptide — and say so plainly.
Better-evidenced route
For metabolic goals: GLP-1
If the goal is metabolic weight management with strong human data, we’ll point you to our GLP-1 programs rather than overstate a preclinical peptide.
Each citation links to the peer-reviewed source for the mechanism described above.
Frequently Asked
MOTS-C is a 16-amino-acid mitochondrial-derived peptide encoded within mitochondrial DNA. In research it activates AMPK and influences insulin sensitivity and metabolism — mostly in preclinical models.
Not robustly. The strong data are preclinical (mice and cells); human clinical-outcome trials are limited, and it is not FDA-approved. We provide it as an eligibility-reviewed, physician-supervised research-peptide.
That description comes from preclinical work showing it triggers metabolic pathways associated with exercise. It is a research concept, not a proven human effect — don’t treat it as a substitute for training.
Prescription-only subcutaneous injection, individualized after a physician review. We don’t publish fixed dosing; your first injection is demonstrated at our Pattaya clinic. Always consult a doctor.
Both relate to mitochondria: SS-31 targets inner-membrane cardiolipin and cristae; MOTS-C is a mitochondrial-derived signalling peptide studied in metabolism. Which (if either) fits is a physician decision.
Yes. Every vial is prepared through a licensed Thai compounding pharmacy ,. Explore more on our peptide therapy hub.
How We Verify · Where To Find Us
Product is prepared by our licensed compounding pharmacy to medical standards — verified at the point of dispense, not from an anonymous online seller.
Licensed medical facility
License No. 72509 · Chon Buri, Thailand. Open Monday–Saturday, 8:00 am – 6:00 pm.
★★★★★ 5.0 from 47 verified Google reviews · Read them on Google
389/203 Moo 12, Bang Lamung, Pattaya, Chon Buri 20150 · +66 84 224 9559
Our Peptide Department covers the full clinical-research spectrum — recovery, growth-hormone support, skin and longevity, libido and visceral fat.
MOTS-C at TRT Bangkok is provided through a dedicated Peptide Department under the TRT Bangkok umbrella. This department has its own protocols, communication system and follow-up structure. Compounded under licensed Bangkok pharmacy · independent peptide protocols · eligibility-reviewed. All claims subject to current Thai regulations · individual eligibility. References available on request. Not for use during pregnancy. Individual results vary.
MOTS-c is one of a newer group of so-called mitochondrial-derived peptides — short sequences encoded within mitochondrial DNA that researchers have linked to metabolism and cellular energy regulation. It is a genuinely interesting area of science, but also an early one: most of the evidence comes from laboratory and animal research, and it has not settled into established clinical use.
For that reason, accuracy means restraint. MOTS-c is a research peptide, not an approved medicine or a metabolic supplement, and the claims that circulate online tend to outrun what the studies actually support. In a responsible setting it is only handled after an eligibility review, with realistic expectations from the outset.
The local dimension in Pattaya is product integrity and informed access. Newer research peptides are especially prone to mislabelling in the grey market, where a buyer has no way of knowing what a vial really contains. Documented sourcing — identity and purity verified by methods such as HPLC and mass spectrometry, held within a 2–8 °C cold chain — provides a level of assurance that an anonymous online order cannot. Correct storage of the reconstituted peptide also matters, and is easier to manage through a controlled local supply.
Our Pattaya clinic on Pratumnak Hill is set up so people can ask what the research does and does not show, how the material is verified, and how eligibility is reviewed — in person or over WhatsApp. Nothing here is medical advice, and no protocol begins without an appropriate eligibility check. The aim is a grounded, honest starting point for understanding MOTS-c locally.
Ready to start MOTS-C in Pattaya?
